Compare Cloudflare Inc (NET) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cloudflare Inc vs Twist Bioscience Corp — how do they compare? Cloudflare Inc trades at $312.83 (market cap $111.87B), while Twist Bioscience Corp trades at $125.52 (market cap $8.26B). The key difference: Cloudflare Inc is far larger — about 13.5× Twist Bioscience Corp's market cap, and Cloudflare Inc is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals.
| NET | TWST | |
|---|---|---|
Market Cap | $111.87B | $8.26B |
Sector | Technology | Health |
52-Week High | $330.74 | $153.10 |
52-Week Low | $160.16 | $24.16 |
Enterprise Value | $111.24B | $8.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cloudflare (NET) trades at $284.41, up 1.97% with strong quarterly earnings beats and positive AI-driven momentum. The stock shows bullish moving averages but neutral oscillators, with key resistance at $292. Revenue growth remains robust at $2.17B for 2025, though profitability challenges persist with a -8.21% net margin. Recent partnerships with OpenAI and government security clearances provide significant growth catalysts.
Outlook remains positive with 72.5% analyst buy ratings and a $347.89 consensus target, representing 22% upside. Key risks include premium valuation (P/S 39.82), ongoing net losses, and competitive pressures in cybersecurity. The AI security positioning and federal contract potential offer substantial growth opportunities if execution succeeds.
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
